Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study

• Published in: Lipids in health and disease Vol. 16; no. 1; p. 165
• Main Authors: Feng, Rennan, Luo, Chao, Li, Chunlong, Du, Shanshan, Okekunle, Akinkunmi Paul, Li, Yanchuan, Chen, Yang, Zi, Tianqi, Niu, Yucun
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 04.09.2017; BioMed Central; BMC
• Subjects: Adult; Body Mass Index; Body weight; Care and treatment; Case-Control Studies; Diabetes mellitus; Diagnosis; Fatty Acids, Monounsaturated - metabolism; Fatty Acids, Unsaturated - metabolism; Female; FFA; gamma-Linolenic Acid - metabolism; Gas Chromatography-Mass Spectrometry; GC-MS; Health aspects; Humans; Liver diseases; Male; Mass spectrometry; Middle Aged; Myristic acid; Myristic Acid - metabolism; NAFLD; Non-alcoholic Fatty Liver Disease - metabolism; Obesity; Obesity - metabolism; Overweight - metabolism; Palmitoleic acid; Thinness - metabolism; FFA; GC-MS; NAFLD; Myristic acid; Palmitoleic acid; Body weight
• ISSN: 1476-511X; 1476-511X
• DOI: 10.1186/s12944-017-0551-1

Non-alcoholic fatty liver disease (NAFLD) given its association with obesity and diabetes may perhaps exert distinct free fatty acids (FFA) pattern, but the understanding of this phenomenon is limited. To this effect, we evaluated FFA profiles among healthy subjects and NAFLD patients stratified by body weight, to identify FFA valuable for early diagnosis of NAFLD. Serum FFA profiles of healthy and NAFLD (lean, overweight and obese) subjects was determined using gas chromatography-mass spectrometry (GC-MS) and distinctions in FFA patterns were evaluated using one-way ANOVA while Receiver operating characteristics (ROC) and logistic regression models were used to explore FFA significant for diagnosing NAFLD. NAFLD patients presented significantly higher (P < 0.05) serum FFA profiles compared to healthy controls (HC). While total FFA profiles were insignificantly different between lean (2093.33 ± 558.11 μg/ml) and overweight (2420.81 ± 555.18 μg/ml) NAFLD patients, obese NAFLD (2739.01 ± 810.35 μg/ml) presented most significantly elevated (P < 0.05) total FFA profiles compared with HC. Of the four FFA; myristic acid (14:0), palmitoleic acid (16:1), γ-linolenic acid (γ-18:3) and cis-7,10,13,16,19-docosapentaenoic acid (22:5), selected in ROC analysis given their high Youden's index and AUC, only 14:0; 5.58(1.37, 22.76) and 16:1; 4.36(1.34, 14.13) had statistical significant odd ratios. Our findings suggest 14:0 and 16:1 are promising for early diagnosis of NAFLD.